chr4-39266152-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_025132.4(WDR19):c.3261+12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,540,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00069 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000085 ( 0 hom. )
Consequence
WDR19
NM_025132.4 intron
NM_025132.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.741
Publications
0 publications found
Genes affected
WDR19 (HGNC:18340): (WD repeat domain 19) The protein encoded by this gene is a member of the WD (tryptophan-aspartic acid) repeat family, which is a large family of structurally-related proteins known to participate in a wide range of cellular processes. Each WD repeat typically contains about 40 amino acids that are usually bracketed by glycine-histidine and tryptophan-aspartic acid (WD) dipeptides. This protein contains six WD repeats, three transmembrane domains, and a clathrin heavy-chain repeat. Mutations in this gene have been described in individuals with a wide range of disorders affecting function of the cilium. These disorders are known as ciliopathies, and include Jeune syndrome, Sensenbrenner syndromes, Senior-Loken syndrome, combined or isolated nephronophthisis (NPHP), and retinitis pigmentosa (RP). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
WDR19 Gene-Disease associations (from GenCC):
- asphyxiating thoracic dystrophy 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cranioectodermal dysplasia 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- nephronophthisis 13Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Senior-Loken syndrome 8Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- cranioectodermal dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Jeune syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 4-39266152-G-A is Benign according to our data. Variant chr4-39266152-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261864.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00069 (105/152228) while in subpopulation AFR AF = 0.00231 (96/41536). AF 95% confidence interval is 0.00194. There are 0 homozygotes in GnomAd4. There are 49 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WDR19 | ENST00000399820.8 | c.3261+12G>A | intron_variant | Intron 29 of 36 | 1 | NM_025132.4 | ENSP00000382717.3 | |||
| WDR19 | ENST00000506869.5 | n.*2842+12G>A | intron_variant | Intron 28 of 35 | 2 | ENSP00000424319.1 | ||||
| WDR19 | ENST00000512095.5 | n.2259+12G>A | intron_variant | Intron 19 of 22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 103AN: 152110Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
103
AN:
152110
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000143 AC: 23AN: 160532 AF XY: 0.000106 show subpopulations
GnomAD2 exomes
AF:
AC:
23
AN:
160532
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000850 AC: 118AN: 1387788Hom.: 0 Cov.: 28 AF XY: 0.0000864 AC XY: 59AN XY: 682752 show subpopulations
GnomAD4 exome
AF:
AC:
118
AN:
1387788
Hom.:
Cov.:
28
AF XY:
AC XY:
59
AN XY:
682752
show subpopulations
African (AFR)
AF:
AC:
87
AN:
31506
American (AMR)
AF:
AC:
2
AN:
34874
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24838
East Asian (EAS)
AF:
AC:
2
AN:
35912
South Asian (SAS)
AF:
AC:
6
AN:
76718
European-Finnish (FIN)
AF:
AC:
0
AN:
49672
Middle Eastern (MID)
AF:
AC:
0
AN:
5614
European-Non Finnish (NFE)
AF:
AC:
16
AN:
1070980
Other (OTH)
AF:
AC:
5
AN:
57674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000690 AC: 105AN: 152228Hom.: 0 Cov.: 31 AF XY: 0.000658 AC XY: 49AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
105
AN:
152228
Hom.:
Cov.:
31
AF XY:
AC XY:
49
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
96
AN:
41536
American (AMR)
AF:
AC:
3
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5184
South Asian (SAS)
AF:
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68014
Other (OTH)
AF:
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nephronophthisis 13 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Senior-Loken syndrome 8 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Asphyxiating thoracic dystrophy 5 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cranioectodermal dysplasia 4 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Asphyxiating thoracic dystrophy 5;C4225376:Senior-Loken syndrome 8 Benign:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
Splicevardb
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.